August 10, 2020 — “I know about people like you.” Twenty-five years after visiting a church in a new community that would would soon be our new home, we still remember those words. Those words come to mind as we read the words of Larry Elliott in the Guardian. Larry Elliott is the economics editor for the Guardian. So […]
August 18, 2017 — Call us superstitious. The hopes for a new diabesity drug – semaglutide – are growing higher. And to us, that’s a good news, bad news story. The high hopes are coming from good clinical results for this new GLP-1 agonist in a head-to-head comparison with dulaglutide from Eli Lilly. Dulaglutide is a GLP-1 activator that’s already on […]
May 12, 2017 — People don’t like surgery. No matter how you put it, knives are scary. Even though data on the benefits of bariatric surgery could hardly be stronger, less than one percent of the people who could benefit actually choose to have bariatric surgery. So it shouldn’t be a surprise that new data on a nonsurgical gastric […]
May 1, 2017 — Making progress with medical devices to treat obesity is a tedious business. And it comes with many ups and downs. But with a more reasonable pathway for FDA approvals these days, more entrepreneurs are trying to advance their ideas. In the latests news, the folks developing a hunger-curbing stent for obesity have raised $2.1 million […]
August 16, 2016 — Bariatric surgery is clearly the most effective option for reversing type 2 diabetes, but for many people, it’s tough to make that leap. So the quest is on to find a less intimidating treatment that delivers the same benefits. A new study in Diabetes Care points to resurfacing the duodenum as a promising possibility. The […]
June 16, 2016 — FDA has just approved a new gastric drain device for the treatment of severe obesity and it’s easy to find people with strong opinions about it. The AspireAssist system consists of a small tube placed through the skin and into the stomach. It connects to a port on the surface of the skin outside the […]
